Literature DB >> 15542888

The rationale for low-dose hormonal therapy.

Rogerio A Lobo1.   

Abstract

A trend in hormonal therapy has been to use a lower dose. The justification for this approach based on both efficacy and safety is presented.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15542888     DOI： 10.1385/ENDO:24:3:217

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.925


  70 in total

Review 1.  Urogenital atrophy and low-dose vaginal estrogen therapy.

Authors:  M Notelovitz
Journal:  Menopause       Date:  2000 May-Jun       Impact factor: 2.953

Review 2.  Hormone therapy to prevent disease and prolong life in postmenopausal women.

Authors:  D Grady; S M Rubin; D B Petitti; C S Fox; D Black; B Ettinger; V L Ernster; S R Cummings
Journal:  Ann Intern Med       Date:  1992-12-15       Impact factor: 25.391

3.  The effects of estrone (Ogen) on spinal bone density of postmenopausal women.

Authors:  S T Harris; H K Genant; D J Baylink; J C Gallagher; S K Karp; M A McConnell; E M Green; R W Stoll
Journal:  Arch Intern Med       Date:  1991-10

4.  Hormone replacement therapy, heart disease, and other considerations.

Authors:  E Barrett-Connor; D Grady
Journal:  Annu Rev Public Health       Date:  1998       Impact factor: 21.981

Review 5.  Improvement in functions of the central nervous system by estrogen replacement therapy might be related with an increased nitric oxide production.

Authors:  P López-Jaramillo; E Terán
Journal:  Endothelium       Date:  1999

6.  Low-dose esterified estrogen therapy: effects on bone, plasma estradiol concentrations, endometrium, and lipid levels. Estratab/Osteoporosis Study Group.

Authors:  H K Genant; J Lucas; S Weiss; M Akin; R Emkey; H McNaney-Flint; R Downs; J Mortola; N Watts; H M Yang; N Banav; J J Brennan; J C Nolan
Journal:  Arch Intern Med       Date:  1997 Dec 8-22

7.  Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen.

Authors:  J C Gallagher; W T Kable; D Goldgar
Journal:  Am J Med       Date:  1991-02       Impact factor: 4.965

8.  Ultralow-dose micronized 17beta-estradiol and bone density and bone metabolism in older women: a randomized controlled trial.

Authors:  Karen M Prestwood; Anne M Kenny; Alison Kleppinger; Martin Kulldorff
Journal:  JAMA       Date:  2003-08-27       Impact factor: 56.272

9.  Continuous combined oestrogen/progestin therapy is well tolerated and increases bone density at the hip and spine in post-menopausal osteoporosis.

Authors:  A B Grey; T F Cundy; I R Reid
Journal:  Clin Endocrinol (Oxf)       Date:  1994-05       Impact factor: 3.478

10.  Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group.

Authors:  J A Cauley; D G Seeley; K Ensrud; B Ettinger; D Black; S R Cummings
Journal:  Ann Intern Med       Date:  1995-01-01       Impact factor: 25.391
View more
  2 in total

Review 1.  Should symptomatic menopausal women be offered hormone therapy?

Authors:  Rogerio A Lobo; Serge Bélisle; William T Creasman; Nancy R Frankel; Neil F Goodman; Janet E Hall; Susan Lee Ivey; Sheryl Kingsberg; Robert Langer; Rebecca Lehman; Donna Behler McArthur; Valerie Montgomery-Rice; Morris Notelovitz; Gary S Packin; Robert W Rebar; MaryEllen Rousseau; Robert S Schenken; Diane L Schneider; Katherine Sherif; Susan Wysocki
Journal:  MedGenMed       Date:  2006

2.  Transdermal hormone therapy in postmenopausal women: a review of metabolic effects and drug delivery technologies.

Authors:  Nathan W Kopper; Jennifer Gudeman; Daniel J Thompson
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.